E-LIB Suche - Ergebnisse für: Ariyasu, Ryo

1

Efficacy of osimertinib in patients with EGFR‐mutation posi..:

Kiritani, Ayu ; Amino, Yoshiaki ; Uchibori, Ken...
Thoracic Cancer. , 2024

Link: https://doi.org/10.1111/..

2

Distinction of ALK fusion gene‐ and EGFR mutation‐positive ..:

Akita, Takahiro ; Ariyasu, Ryo ; Kakuto, Sho...
Thoracic Cancer. 15 (2024) 10 - p. 788-796 , 2024

Link: https://doi.org/10.1111/..

3

Soluble interleukin-2 receptor as a predictive biomarker fo..:

Tozuka, Takehiro ; Yanagitani, Noriko ; Yoshida, Hiroshi...
Investigational New Drugs. 41 (2023) 3 - p. 411-420 , 2023

Link: https://doi.org/10.1007/..

4

Real-World Outcome Analysis of Patients With Stage IV NSCLC..:

Ariyasu, Ryo ; Kakuto, Sho ; Miyadera, Keiki...
JTO Clinical and Research Reports. 4 (2023) 6 - p. 100524 , 2023

Link: https://doi.org/10.1016/..

5

Clinical characteristics of patients with KRAS mutation det..:

Amino, Yoshiaki ; Low, Siew‐Kee ; Ninomiya, Hironori...
Thoracic Cancer. 14 (2023) 33 - p. 3317-3322 , 2023

Link: https://doi.org/10.1111/..

6

Second-line immunosuppressant administration for steroid-re..:

Ogusu, Shinsuke ; Harutani, Yuhei ; Tozuka, Takehiro...
Cancer Immunology, Immunotherapy. 72 (2023) 11 - p. 3765-3772 , 2023

Link: https://doi.org/10.1007/..

7

Subsequent treatment for locally advanced non-small-cell lu..:

Hasegawa, Tsukasa ; Ariyasu, Ryo ; Tanaka, Hisashi...
Cancer Chemotherapy and Pharmacology. 92 (2023) 1 - p. 29-37 , 2023

Link: https://doi.org/10.1007/..

8

PD-1 blockade therapy promotes infiltration of tumor-attack..:

Nagasaki, Joji ; Inozume, Takashi ; Sax, Nicolas...
Cell Reports. 38 (2022) 5 - p. 110331 , 2022

Link: https://doi.org/10.1016/..

9

Myocarditis associated with immune-checkpoint inhibitors di..:

Fukumitsu, Masafumi ; Ariyasu, Ryo ; Ishiyama, Mitsutomi...
International Cancer Conference Journal. 12 (2022) 2 - p. 109-114 , 2022

Link: https://doi.org/10.1007/..

10

EGFR-TKI re-administration after osimertinib failure in T79..:

Ogusu, Shinsuke ; Ariyasu, Ryo ; Akita, Takahiro...
Investigational New Drugs. 40 (2022) 6 - p. 1342-1349 , 2022

Link: https://doi.org/10.1007/..

11

Microsecond-timescale MD simulation of EGFR minor mutation ..:

Yoshizawa, Takahiro ; Uchibori, Ken ; Araki, Mitsugu...
npj Precision Oncology. 5 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

12

Characteristics of central nervous system progression in no..:

Sakamoto, Hiroaki ; Yanagitani, Noriko ; Manabe, Ryo...
Cancer Reports. 4 (2021) 6 - p. , 2021

Link: https://doi.org/10.1002/..

13

Clinical influence of switching companion diagnostic tests ..:

Uchibori, Ken ; Takano, Natsuki ; Manabe, Ryo...
Thoracic Cancer. 12 (2021) 6 - p. 906-913 , 2021

Link: https://doi.org/10.1111/..

14

Monitoring epidermal growth factor receptor C797S mutation ..:

Ariyasu, Ryo ; Uchibori, Ken ; Sasaki, Takaaki...
Cancer Science. 112 (2021) 6 - p. 2371-2380 , 2021

Link: https://doi.org/10.1111/..

15

Phase II study of the combination of S-1 with bevacizumab f..:

Hasegawa, Tsukasa ; Yanagitani, Noriko ; Ohyanagi, Fumiyoshi...
International Journal of Clinical Oncology. 26 (2020) 3 - p. 507-514 , 2020

Link: https://doi.org/10.1007/..